Specific Serum Ig Recognizing Staphylococcal Wall Teichoic Acid Induces Complement-Mediated Opsonophagocytosis against Staphylococcus aureus

Wall teichoic acid (WTA) of Staphylococcus aureus is a major cell envelope-associated glycopolymer that is a key molecule in promoting colonization during S. aureus infection. The complement system plays a key role in the opsonization and clearance of pathogens. We recently reported that S. aureus WTA functions as a ligand of human serum mannose-binding lectin (MBL), a recognition molecule of the lectin complement pathway. Intriguingly, serum MBL in adults does not bind to WTA because of an inhibitory effect of serum anti–WTA-IgG. In this study, serum anti–WTA-IgG was purified to homogeneity using a purified S. aureus WTA-coupled affinity column to examine the biological function of human anti–WTA-IgG. The purified anti–WTA-IgG contained the IgG2 subclass as a major component and specifically induced C4 and C3 deposition on the S. aureus surface in the anti–WTA-IgG–depleted serum, but not in C1q-deficient serum. Furthermore, the anti–WTA-IgG–dependent C3 deposition induced phagocytosis of S. aureus cells by human polymorphonuclear leukocytes. These results demonstrate that serum anti–WTA-IgG is a real trigger for the induction of classical complement-dependent opsonophagocytosis against S. aureus. Our results also support the fact that a lack of the lectin complement pathway in MBL-deficient adults is compensated by Ag-specific, Ab-mediated adaptive immunity.

[1]  Seulggie Choi,et al.  Identification of staphylococcal lipoteichoic acid-binding proteins in human serum by high-resolution LTQ-Orbitrap mass spectrometry. , 2012, Molecular immunology.

[2]  L. Trouw,et al.  Complement activation by (auto-) antibodies. , 2011, Molecular immunology.

[3]  John D Lambris,et al.  Complement: a key system for immune surveillance and homeostasis , 2010, Nature Immunology.

[4]  K. Kurokawa,et al.  Inhibitory Role for d-Alanylation of Wall Teichoic Acid in Activation of Insect Toll Pathway by Peptidoglycan of Staphylococcus aureus , 2010, The Journal of Immunology.

[5]  M. Matsushita,et al.  Human Serum Mannose-binding Lectin Senses Wall Teichoic Acid Glycopolymer of Staphylococcus aureus, Which Is Restricted in Infancy* , 2010, The Journal of Biological Chemistry.

[6]  R. Möllby,et al.  Levels of Antibody against 11 Staphylococcus aureus Antigens in a Healthy Population , 2010, Clinical and Vaccine Immunology.

[7]  T. Kohler,et al.  The wall teichoic acid and lipoteichoic acid polymers of Staphylococcus aureus. , 2010, International journal of medical microbiology : IJMM.

[8]  K. Kurokawa,et al.  Shuttle vectors derived from pN315 for study of essential genes in Staphylococcus aureus. , 2010, Biological & pharmaceutical bulletin.

[9]  K. Shimizu,et al.  Auxiliary role for d‐alanylated wall teichoic acid in Toll‐like receptor 2‐mediated survival of Staphylococcus aureus in macrophages , 2010, Immunology.

[10]  M. Levine,et al.  Immunology of combining CRM(197) conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants. , 2009, Vaccine.

[11]  J. Nicolás,et al.  Is mannose-binding lectin deficiency associated with infection due to Gram-positive bacteria? , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  K. Kurokawa,et al.  Pleiotropic Roles of Polyglycerolphosphate Synthase of Lipoteichoic Acid in Growth of Staphylococcus aureus Cells , 2008, Journal of bacteriology.

[13]  M. Boermeester,et al.  Low Serum Mannose-Binding Lectin Level Increases the Risk of Death due to Pneumococcal Infection , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  C. Weidenmaier,et al.  Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions , 2008, Nature Reviews Microbiology.

[15]  Timothy Foster,et al.  Key Role for Clumping Factor B in Staphylococcus aureus Nasal Colonization of Humans , 2008, PLoS medicine.

[16]  J. Y. Kim,et al.  Mannose‐binding lectin without the aid of its associated serine proteases alters lipopolysaccharide‐mediated cytokine/chemokine secretion from human endothelial cells , 2007, Immunology.

[17]  O. Schneewind,et al.  Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus , 2007, Proceedings of the National Academy of Sciences.

[18]  C. Kaito,et al.  Colony Spreading in Staphylococcus aureus , 2006, Journal of bacteriology.

[19]  J. Dengjel,et al.  Staphylococcus aureus Deficient in Lipidation of Prelipoproteins Is Attenuated in Growth and Immune Activation , 2005, Infection and Immunity.

[20]  B. Kocsis,et al.  Comparison of Antibody Repertoires against Staphylococcus aureus in Healthy Individuals and in Acutely Infected Patients , 2005, Clinical Diagnostic Laboratory Immunology.

[21]  T. Fujita,et al.  Role of L-Ficolin/Mannose-Binding Lectin-Associated Serine Protease Complexes in the Opsonophagocytosis of Type III Group B Streptococci1 , 2005, The Journal of Immunology.

[22]  A. Fattom,et al.  Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients. , 2004, Vaccine.

[23]  B. Neumeister,et al.  Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections , 2004, Nature Medicine.

[24]  D. Jack,et al.  Enhancement of Complement Activation and Opsonophagocytosis by Complexes of Mannose-Binding Lectin with Mannose-Binding Lectin-Associated Serine Protease After Binding to Staphylococcus aureus1 , 2002, The Journal of Immunology.

[25]  T. Fujita Evolution of the lectin–complement pathway and its role in innate immunity , 2002, Nature Reviews Immunology.

[26]  M. G. Finn,et al.  Click Chemistry: Diverse Chemical Function from a Few Good Reactions. , 2001, Angewandte Chemie.

[27]  M. Walport,et al.  Complement. Second of two parts. , 2001, The New England journal of medicine.

[28]  M. Walport Complement. First of two parts. , 2001, The New England journal of medicine.

[29]  M. Melbye,et al.  Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. , 2001, JAMA.

[30]  D. Jack,et al.  Mannose-Binding Lectin Binds to a Range of Clinically Relevant Microorganisms and Promotes Complement Deposition , 2000, Infection and Immunity.

[31]  William Wiley Navarre,et al.  Surface Proteins of Gram-Positive Bacteria and Mechanisms of Their Targeting to the Cell Wall Envelope , 1999, Microbiology and Molecular Biology Reviews.

[32]  A. Conde Staphylococcus aureus infections. , 1998, The New England journal of medicine.

[33]  B. Söderquist,et al.  Antibody response in Staphylococcus aureus septicaemia--a prospective study. , 1998, Journal of medical microbiology.

[34]  Wiklund Ra,et al.  First of two parts , 1997 .

[35]  D. Coggon,et al.  Prospective cohort study of predictors of incident low back pain in nurses , 1997, BMJ.

[36]  J. Kornblum,et al.  Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. , 1993, The EMBO journal.

[37]  S. Thiel,et al.  ASSOCIATION OF LOW LEVELS OF MANNAN-BINDING PROTEIN WITH A COMMON DEFECT OF OPSONISATION , 1989, The Lancet.

[38]  S. Morrison,et al.  Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. , 1988, The EMBO journal.

[39]  M. Brüggemann,et al.  Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q , 1988, The Journal of experimental medicine.

[40]  M. Neuberger,et al.  Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies , 1987, The Journal of experimental medicine.

[41]  S. A. Hedström,et al.  A new serological assay for Staphylococcus aureus infections: detection of IgG antibodies to S. aureus lipase with an enzyme-linked immunosorbent assay. , 1985, The Journal of infectious diseases.

[42]  H. Verbrugh,et al.  Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement. , 1982, Journal of immunology.

[43]  H. Verbrugh,et al.  Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leucocytes. , 1978, Journal of clinical pathology.

[44]  A. Michael,et al.  Dichotomy between opsonization and serum complement activation by encapsulated staphylococci , 1978, Infection and Immunity.

[45]  P. Peterson,et al.  Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes , 1978, Infection and immunity.

[46]  J. Ravetch,et al.  Fcγ receptors as regulators of immune responses , 2008, Nature Reviews Immunology.

[47]  J. Ravetch,et al.  Fcgamma receptors as regulators of immune responses. , 2008, Nature reviews. Immunology.

[48]  R. Dziarski,et al.  Isolation of peptidoglycan and soluble peptidoglycan fragments. , 1994, Methods in enzymology.

[49]  K. Joiner,et al.  Complement and bacteria: chemistry and biology in host defense. , 1984, Annual review of immunology.